In vivo and in vitro cardiac responses to beta-adrenergic stimulation in volume-overload heart failure

Journal of Molecular and Cellular Cardiology

Volumn 57, Issue 1, 2013, Pages 47-58

  Guggilam, Anuradha ^a,b   Hutchinson, Kirk R ^a,c   West, T Aaron ^a   Kelly, Amy P ^a   Galantowicz, Maarten L ^a   Davidoff, Amy J ^d   Sadayappan, Sakthivel ^e   Lucchesi, Pamela A ^a,b  

^a THE RESEARCH INSTITUTE AT NATIONWIDE CHILDREN S HOSPITAL   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c LOUISIANA STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF NEW ENGLAND   (United States)

^e LOYOLA UNIVERSITY CHICAGO   (United States)

Author keywords

adrenergic system; Cardiomyocytes; Congestive heart failure; Volume overload

Indexed keywords

CALCIUM ION; CONNEXIN 43; DOBUTAMINE; MYOSIN HEAVY CHAIN BETA; PROTEIN C; PROTEIN ZO1; RYANODINE RECEPTOR; SARCOPLASMIC RETICULUM CALCIUM TRANSPORTING ADENOSINE TRIPHOSPHATASE; SERINE; TROPONIN I;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; AORTOCAVAL FISTULA; ARTICLE; BETA ADRENERGIC STIMULATION; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DESENSITIZATION; HEART LEFT VENTRICLE CONTRACTION; HEART LEFT VENTRICLE ENDSYSTOLIC VOLUME; HEART LEFT VENTRICLE OVERLOAD; HEART LEFT VENTRICLE RELAXATION; HEART MUSCLE POTENTIAL; HEART VENTRICLE REMODELING; IN VITRO STUDY; IN VIVO STUDY; INOTROPISM; LOW DRUG DOSE; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFECT; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; SARCOMERE; SYSTOLIC BLOOD PRESSURE; SYSTOLIC DYSFUNCTION; TRANSTHORACIC ECHOCARDIOGRAPHY;

ADRENERGIC BETA-AGONISTS; ANIMALS; CALCIUM SIGNALING; CELLS, CULTURED; CONNEXIN 43; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; GENE EXPRESSION; HEART FAILURE; HEART VENTRICLES; ISOPROTERENOL; KINETICS; MALE; MYOCARDIAL CONTRACTION; MYOCYTES, CARDIAC; RATS; RATS, SPRAGUE-DAWLEY; TROPONIN I; VENTRICULAR MYOSINS; VENTRICULAR REMODELING;

FISTULA; RATTUS;

EID: 84873427034     PISSN: 00222828     EISSN: 10958584     Source Type: Journal    
DOI: 10.1016/j.yjmcc.2012.11.013     Document Type: Article

References (51)

1. Carabello B.A. Models of volume overload hypertrophy. J Card Fail 1996, 2:55-64.
2. Ryan T.D., Rothstein E.C., Aban I., Tallaj J.A., Husain A., Lucchesi P.A., et al. Left ventricular eccentric remodeling and matrix loss are mediated by bradykinin and precede cardiomyocyte elongation in rats with volume overload. J Am Coll Cardiol 2007, 49:811-821.
3. Ding Y.F., Brower G.L., Zhong Q., Murray D., Holland M., Janicki J.S., et al. Defective intracellular Ca2+ homeostasis contributes to myocyte dysfunction during ventricular remodelling induced by chronic volume overload in rats. Clin Exp Pharmacol Physiol 2008, 35:827-835.
4. McNicholas-Bevensee C.M., DeAndrade K.B., Bradley W.E., Dell'Italia L.J., Lucchesi P.A., Bevensee M.O. Activation of gadolinium-sensitive ion channels in cardiomyocytes in early adaptive stages of volume overload-induced heart failure. Cardiovasc Res. 2006 Nov 1, 72(2):262-270.
5. Takahashi T., Allen P.D., Lacro R.V., Marks A.R., Dennis A.R., Schoen F.J., et al. Expression of dihydropyridine receptor (Ca2+ channel) and calsequestrin genes in the myocardium of patients with end-stage heart failure. J Clin Invest 1992, 90:927-935.
6. Hasenfuss G., Schillinger W., Lehnart S.E., Preuss M., Pieske B., Maier L.S., et al. Relationship between Na+-Ca2+-exchanger protein levels and diastolic function of failing human myocardium. Circulation 1999, 99:641-648.
7. Chidsey C.A., Braunwald E., Morrow A.G., Mason D.T. Myocardial norepinephrine concentration in man. Effects of reserpine and of congestive heart failure. N Engl J Med 1963, 269:653-658.
8. Wang X., Sentex E., Saini H.K., Chapman D., Dhalla N.S. Upregulation of beta-adrenergic receptors in heart failure due to volume overload. Am J Physiol Heart Circ Physiol 2005, 289:H151-H159.
9. Hutchinson K.R., Guggilam A., Cismowski M.J., Galantowicz M.L., West T.A., Stewart J.A., et al. Temporal pattern of left ventricular structural and functional remodeling following reversal of volume overload heart failure. J Appl Physiol 2011, 111:1778-1788.
10. Shenouda S.K., Lord K.C., McIlwain E., Lucchesi P.A., Varner K.J. Ecstasy produces left ventricular dysfunction and oxidative stress in rats. Cardiovasc Res 2008, 79:662-670.
11. Govindan S., McElligott A., Muthusamy S., Nair N., Barefield D., Martin J.L., et al. Cardiac myosin binding protein-C is a potential diagnostic biomarker for myocardial infarction. J Mol Cell Cardiol 2012, 52:154-164.
12. Wold L.E., Dutta K., Mason M.M., Ren J., Cala S.E., Schwanke M.L., et al. Impaired SERCA function contributes to cardiomyocyte dysfunction in insulin resistant rats. J Mol Cell Cardiol 2005, 39:297-307.
13. Nakao K., Minobe W., Roden R., Bristow M.R., Leinwand L.A. Myosin heavy chain gene expression in human heart failure. J Clin Invest 1997, 100:2362-2370.
14. Miyata S., Minobe W., Bristow M.R., Leinwand L.A. Myosin heavy chain isoform expression in the failing and nonfailing human heart. Circ Res 2000, 86:386-390.
15. Tuttle R.R., Mills J. Dobutamine: development of a new catecholamine to selectively increase cardiac contractility. Circ Res 1975, 36:185-196.
16. Swynghedauw B., Baillard C. Biology of hypertensive cardiopathy. Curr Opin Cardiol 2000, 15:247-253.
17. Lompre A.M., Hajjar R.J., Harding S.E., Kranias E.G., Lohse M.J., Marks A.R. Ca2+ cycling and new therapeutic approaches for heart failure. Circulation 2010, 121:822-830.
18. Juric D., Yao X., Thandapilly S., Louis X., Cantor E., Chaze B., et al. Defects in ryanodine receptor function are associated with systolic dysfunction in rats subjected to volume overload. Exp Physiol 2010, 95:869-879.
19. Hisamatsu Y., Ohkusa T., Kihara Y., Inoko M., Ueyama T., Yano M., et al. Early changes in the functions of cardiac sarcoplasmic reticulum in volume-overloaded cardiac hypertrophy in rats. J Mol Cell Cardiol 1997, 29:1097-1109.
20. Shan J., Betzenhauser M.J., Kushnir A., Reiken S., Meli A.C., Wronska A., Dura M., Chen B.X., Marks A.R. Role of chronic ryanodine receptor phosphorylation in heart failure and β-adrenergic receptor blockade in mice. J Clin Invest. 2010, 120(12):4375-4387.
21. Oda T., Yano M., Yamamoto T., Tokuhisa T., Okuda S., Doi M., et al. Defective regulation of interdomain interactions within the ryanodine receptor plays a key role in the pathogenesis of heart failure. Circulation 2005, 111:3400-3410.
22. Wehrens X.H., Lehnart S.E., Reiken S., Vest J.A., Wronska A., Marks A.R. Ryanodine receptor/calcium release channel PKA phosphorylation: a critical mediator of heart failure progression. Proc Natl Acad Sci U S A 2006, 103:511-518.
23. Wang W., Zhu W., Wang S., Yang D., Crow M.T., Xiao R.P., et al. Sustained beta1-adrenergic stimulation modulates cardiac contractility by Ca2+/calmodulin kinase signaling pathway. Circ Res 2004, 95:798-806.
24. Ai X., Curran J.W., Shannon T.R., Bers D.M., Pogwizd S.M. Ca2+/calmodulin-dependent protein kinase modulates cardiac ryanodine receptor phosphorylation and sarcoplasmic reticulum Ca2+ leak in heart failure. Circ Res 2005, 97:1314-1322.
25. Marx S.O., Reiken S., Hisamatsu Y., Jayaraman T., Burkhoff D., Rosemblit N., et al. PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts. Cell 2000, 101:365-376.
26. Bers D.M., Eisner D.A., Valdivia H.H. Sarcoplasmic reticulum Ca2+ and heart failure: roles of diastolic leak and Ca2+ transport. Circ Res 2003, 93:487-490.
27. Pogwizd S.M., Qi M., Yuan W., Samarel A.M., Bers D.M. Upregulation of Na+/Ca2+ exchanger expression and function in an arrhythmogenic rabbit model of heart failure. Circ Res 1999, 85:1009-1019.
28. O'Rourke B., Kass D.A., Tomaselli G.F., Kääb S., Tunin R., Marbán E. Mechanisms of altered excitation-contraction coupling in canine tachycardia-induced heart failure, i: experimental studies. Circ Res 1999, 84:562-570.
29. Jiang M.T., Lokuta A.J., Farrell E.F., Wolff M.R., Haworth R.A., Valdivia H.H. Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure. Circ Res 2002, 91:1015-1022.
30. Stelzer J.E., Brickson S.L., Locher M.R., Moss R.L. Role of myosin heavy chain composition in the stretch activation response of rat myocardium. J Physiol 2007, 579:161-173.
31. Hart D.L., Heidkamp M.C., Iyengar R., Vijayan K., Szotek E.L., Barakat J.A., et al. CRNK gene transfer improves function and reverses the myosin heavy chain isoenzyme switch during post-myocardial infarction left ventricular remodeling. J Mol Cell Cardiol 2008, 45:93-105.
32. Li X.M., Ma Y.T., Yang Y.N., Liu F., Chen B.D., Han W., et al. Downregulation of survival signalling pathways and increased apoptosis in the transition of pressure overload-induced cardiac hypertrophy to heart failure. Clin Exp Pharmacol Physiol 2009, 36:1054-1061.
33. James J., Hor K., Moga M.A., Martin L.A., Robbins J. Effects of myosin heavy chain manipulation in experimental heart failure. J Mol Cell Cardiol 2010, 48:999-1006.
34. Zhang R., Zhao J., Mandveno A., Potter J.D. Cardiac troponin I phosphorylation increases the rate of cardiac muscle relaxation. Circ Res 1995, 76:1028-1035.
35. Li L., Desantiago J., Chu G., Kranias E.G., Bers D.M. Phosphorylation of phospholamban and troponin I in beta-adrenergic-induced acceleration of cardiac relaxation. Am J Physiol Heart Circ Physiol 2000, 278:H769-H779.
36. McClellan G., Kulikovskaya I., Winegrad S. Changes in cardiac contractility related to calcium-mediated changes in phosphorylation of myosin-binding protein C. Biophys J 2001, 81:1083-1092.
37. Sadayappan S., Gulick J., Osinska H., Barefield D., Cuello F., Avkiran M., et al. A critical function for Ser-282 in cardiac myosin binding protein-C phosphorylation and cardiac function. Circ Res 2011, 109:141-150.
38. Yuan C., Guo Y., Ravi R., Przyklenk K., Shilkofski N., Diez R., et al. Myosin binding protein C is differentially phosphorylated upon myocardial stunning in canine and rat hearts - evidence for novel phosphorylation sites. Proteomics 2006, 6:4176-4186.
39. Sadayappan S., Gulick J., Osinska H., Martin L.A., Hahn H.S., Dorn G.W., et al. Cardiac myosin-binding protein-C phosphorylation and cardiac function. Circ Res 2005, 97:1156-1163.
40. van Dijk S.J., Dooijes D., dos Remedios C., Michels M., Lamers J.M., Winegrad S., et al. Cardiac myosin-binding protein C mutations and hypertrophic cardiomyopathy: haploinsufficiency, deranged phosphorylation, and cardiomyocyte dysfunction. Circulation 2009, 119:1473-1483.
41. Marston S., Copeland O., Jacques A., Livesey K., Tsang V., McKenna W.J., et al. Evidence from human myectomy samples that MYBPC3 mutations cause hypertrophic cardiomyopathy through haploinsufficiency. Circ Res 2009, 105:219-222.
42. Wang X., Sentex E., Chapman D., Dhalla N.S. Alterations of adenylyl cyclase and G proteins in aortocaval shunt-induced heart failure. Am J Physiol Heart Circ Physiol. 2004, 287(1):H118-H125.
43. Sethi R., Saini H.K., Guo X., Wang X., Elimban V., Dhalla N.S. Dependence of changes in beta-adrenoceptor signal transduction on type and stage of cardiac hypertrophy. J Appl Physiol 2007, 102:978-984.
44. Communal C., Ribuot C., Durand A., Demenge P. Myocardial beta-adrenergic reactivity in volume overload-induced cardiac hypertrophy in the rat. Fundam Clin Pharmacol 1998, 12:411-419.
45. Teunissen B.E., Jongsma H.J., Bierhuizen M.F. Regulation of myocardial connexins during hypertrophic remodelling. Eur Heart J 2004, 25:1979-1989.
46. Fernandez-Cobo M., Gingalewski C., Drujan D., De Maio A. Downregulation of connexin 43 gene expression in rat heart during inflammation. The role of tumour necrosis factor. Cytokine 1999, 11:216-224.
47. Emdad L., Uzzaman M., Takagishi Y., Honjo H., Uchida T., Severs N.J., et al. Gap junction remodeling in hypertrophied left ventricles of aortic-banded rats: prevention by angiotensin II type 1 receptor blockade. J Mol Cell Cardiol 2001, 33:219-231.
48. Gilleron J., Carette D., Fiorini C., Benkdane M., Segretain D., Pointis G. Connexin 43 gap junction plaque endocytosis implies molecular remodelling of ZO-1 and c-Src partners. Commun Integr Biol 2009, 2:104-106.
49. Toyofuku T., Yabuki M., Otsu K., Kuzuya T., Tada M., Hori M. Functional role of c-Src in gap junctions of the cardiomyopathic heart. Circ Res 1999, 85:672-681.
50. Wang X.H., Zhuo X.Z., Ni Y.J., Gong M., Wang T.Z., Lu Q., et al. Improvement of cardiac function and reversal of gap junction remodeling by Neuregulin-1beta in volume-overloaded rats with heart failure. J Geriatr Cardiol 2012, 9:172-179.
51. Davey P. QT interval lengthening in cardiac disease relates more to left ventricular systolic dysfunction than to autonomic function. Eur J Heart Fail 2000, 2:265-271.